🔎 Trials Near Me

Home › Prostate Cancer › Louisiana

Prostate Cancer clinical trials in Louisiana

23 studies for Prostate Cancer are looking for participants at sites in Louisiana.

Cities in Louisiana

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • LSU Health Baton Rouge-North Clinic, Baton Rouge
  • Our Lady of the Lake Physician Group, Baton Rouge
  • Our Lady of The Lake, Baton Rouge
  • and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Northshore Oncology Associates-Covington, Covington
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

  • Southern Urology LLC, Lafayette
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07832292

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • XCancer Research Network LCMC Health EJGH, Metairie
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • East Jefferson Hospital, Metairie
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Louisiana State University, New Orleans
  • WK Clinical Research, Shreveport
Recruiting
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Mary Bird Perkins Cancer Center - Gonzales, Gonzales
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • Ochsner Health - Ochsner Medical Center - New Orleans, New Orleans
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07005154

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

  • Research Site, Metairie
RecruitingPhase 1/2
Ages 18 to 99 · Men · Updated Aug 27, 2026 · NCT07590934

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Metairie
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Ochsner, Jefferson
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • LSU Health Baton Rouge-North Clinic, Baton Rouge
  • Our Lady of the Lake Physician Group, Baton Rouge
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

  • WK Advanced Urology Specialists, Bossier City
RecruitingObservational study
All ages · Men · Updated Aug 18, 2026 · NCT07455058

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • East Jefferson General Hospital Metairie, New Orleans
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498

PSMA PET Combined With MRI for the Detection of PCa

  • Southern Urology, Lafayette
  • Ochsner Clinic Foundation, New Orleans
RecruitingPhase 3Healthy volunteers welcome
Ages 18 and older · Men · Updated Jul 23, 2026 · NCT07052214

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
  • University Medical Center New Orleans, New Orleans
  • and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Tulane Cancer Center, New Orleans
  • Ochsner Clinic Foundation, New Orleans
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Research Site, Metairie
RecruitingPhase 1
Ages 18 and older · Men · Updated May 12, 2026 · NCT06879041

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
  • Louisiana State University Health Science Center, New Orleans
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515

Vitamin D for Prostate Endocrine Therapy

  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
RecruitingPhase 3
Ages 50 and older · Men · Updated Jan 15, 2026 · NCT05838716

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Orleans
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • East Jefferson General Hospital, Metairie
  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.